See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2015_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 172,731,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 19,274,000 |
| 3 | remainder_Assets | 464,000 |
| 4 | LiabilitiesCurrent | 10,236,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,864,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,043,000 |
| 9 | ResearchAndDevelopmentExpense | 33,390,000 |
| 10 | remainder_Expenses | 12,823,000 |
| 11 | remainder_Revenues | 383,000 |
| 12 | remainder_NetIncome | 1,956,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 192,469,000 |
| 1 | Liabilities | 16,100,000 |
| 2 | Expenses | 65,256,000 |
| 3 | Revenues | 383,000 |
| 4 | StockholdersEquity | 176,369,000 |
| 5 | NetIncome | -62,917,000 |
| 6 | ComprehensiveNetIncome | -62,917,000 |
| 7 | BaseVar | 138,082,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.08 |
| 9 | EconomicCapitalRatio | 3.74 |
Edgar->Model Mapping
Feature Distribution
